Dow Up0.05% Nasdaq Down0.13%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
7.15 Down 0.33(4.41%) 3:52PM EDT - Nasdaq Real Time Price
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents15,121  14,940  9,311  
Short Term Investments24,172  56,287  34,804  
Net Receivables -   -   -  
Inventory -   -   -  
Other Current Assets1,199  1,705  1,550  
Total Current Assets 40,492   72,932   45,665  
Long Term Investments -   -   -  
Property Plant and Equipment23  43  74  
Goodwill -   -   -  
Intangible Assets -   -   -  
Accumulated Amortization -   -   -  
Other Assets10  42  130  
Deferred Long Term Asset Charges -   -   -  
Total Assets 40,525   73,017   45,869  
Liabilities
Current Liabilities
Accounts Payable9,067  9,105  8,383  
Short/Current Long Term Debt9,018  6,610   -  
Other Current Liabilities15,887  16,026   -  
Total Current Liabilities 33,972   31,741   8,383  
Long Term Debt9,025  17,651  9,453  
Other Liabilities -   -   -  
Deferred Long Term Liability Charges3,712  11,668  13  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 46,709   61,060   17,849  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock5  5  5  
Retained Earnings(479,695)(445,097)(401,146)
Treasury Stock -   -   -  
Capital Surplus473,509  457,011  429,142  
Other Stockholder Equity(3)38  19  
Total Stockholder Equity (6,184) 11,957   28,020  
Net Tangible Assets (6,184) 11,957   28,020  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.